Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2004

View Archived Issues

Numax enters new phase III RSV study in Native American infants

New U.S. site added to phase II ProCord study for acute spinal cord injury

Tetrodin studied in phase II trial of opiate-dependent subjects

Full enrollment achieved in phase III study of Celacade for PAD

Lorus signs Virulizin supply agreement with BioVectra

Crucell highlights progress

Doxorubicin Transdrug receives European orphan drug status

Fast track status for XP-12B for menorrhagia

Australian phase II study of Testosterone MDTS completed

Raven files IND for phase I study of RAV-12 in advanced adenocarcinoma

Nesterone MDTS contraceptive spray enters clinical testing

In vitro and in vivo characterization of SLV-326, a novel cannabinoid CB1 receptor antagonist

Aldosterone synthase inhibition with FAD-286: a novel therapy for the treatment of CHF

HS-2-45: a novel anticonvulsant reported to modulate Na+ channel gating

In vitro, in vivo characterization of JNJ-17308616, a novel anxiolytic V1a receptor antagonist

Scientists at AmorePacific claim genistein for the treatment of obesity

ARS investigators describe a new use of clusterin for peripheral neurological diseases

New use of ritonavir for unconjugated hyperbilirubinemia claimed by Abbott

Vertex patent covers protein kinase inhibitors

Protein kinase modulators claimed by Exelixis

GSK-3beta inhibitors for the treatment of neurodegenerative diseases

Antiatherosclerotic effects of oral apolipoprotein A-I mimetic

Phase II data on the immunogenicity of the influenza vaccine FluBlok in elderly subjects

Preclinical profile of WAY-909, a novel selective 5-HT2C receptor selective agonist

Rosuvastatin significantly improves hypercholesterolemia in African Americans

Pexelizumab reduces mortality in patients undergoing CABG and aortic valve surgery

Antiviral effects, pharmacokinetics and safety of VX-950 in HCV infection

Update on the antitumor effects and safety of lapatinib in advanced breast cancer

Safety, distribution of ChimeriVax-West Nile vaccine assessed in monkeys

Vaxfectin enhances antimalarial plasmid DNA vaccines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...